Liu J, Yu C, Wu H, Chang Y, Lin C, Lu C
Sci Rep. 2021; 11(1):13599.
PMID: 34193921
PMC: 8245468.
DOI: 10.1038/s41598-021-92793-w.
Leoh L, Daniels-Wells T, Penichet M
Curr Top Microbiol Immunol. 2015; 388:109-49.
PMID: 25553797
PMC: 4452505.
DOI: 10.1007/978-3-319-13725-4_6.
Reginald K, Eckl-Dorna J, Zafred D, Focke-Tejkl M, Lupinek C, Niederberger V
Immunol Cell Biol. 2012; 91(2):167-72.
PMID: 23229638
PMC: 6606442.
DOI: 10.1038/icb.2012.70.
Singh A, Vastert S, Prakken B, Illges H
Rheumatol Int. 2011; 32(6):1581-7.
PMID: 21328056
DOI: 10.1007/s00296-011-1830-1.
Morris J, Waldmann T
Expert Rev Mol Med. 2009; 11:e29.
PMID: 19788782
PMC: 7294739.
DOI: 10.1017/S1462399409001215.
Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.
Liu D, Zhu J, Niu Z
Clin Vaccine Immunol. 2008; 15(6):901-10.
PMID: 18400970
PMC: 2446622.
DOI: 10.1128/CVI.00465-07.
CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids.
Mayer R, Flamberg P, Katchur S, Bolognese B, Smith D, Marolewski A
Inflamm Res. 2002; 51(2):85-90.
PMID: 11926319
DOI: 10.1007/BF02684008.
Metalloprotease inhibitor-mediated inhibition of mouse immunoglobulin production.
Kilmon M, Mayer R, Marshall L, Conrad D
Immunology. 2001; 102(3):281-8.
PMID: 11298826
PMC: 1783188.
DOI: 10.1046/j.1365-2567.2001.01188.x.
Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA).
Ribbens C, Bonnet V, Kaiser M, Andre B, Kaye O, Franchimont N
Clin Exp Immunol. 2000; 120(1):194-9.
PMID: 10759783
PMC: 1905611.
DOI: 10.1046/j.1365-2249.2000.01198.x.
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debre P
J Neurosci. 1999; 19(9):3440-7.
PMID: 10212304
PMC: 6782235.
Surface expression and release of soluble forms of CD8 and CD23 in CD40- and IL-4-activated mononuclear cells from patients with Graves' disease (GD).
Itoh M, Uchimura K, Hayakawa N, Makino M, Hayashi R, Nagata M
Clin Exp Immunol. 1998; 113(2):309-14.
PMID: 9717983
PMC: 1905036.
DOI: 10.1046/j.1365-2249.1998.00658.x.
High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects.
Ying S, Barata L, Meng Q, Grant J, Barkans J, Durham S
Immunology. 1998; 93(2):281-8.
PMID: 9616380
PMC: 1364190.
DOI: 10.1046/j.1365-2567.1998.00418.x.
Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: stimulation by soluble CD23.
Roman V, Dugas N, ABADIE A, Amirand C, Zhao H, Dugas B
Immunology. 1997; 91(4):643-8.
PMID: 9378507
PMC: 1363888.
DOI: 10.1046/j.1365-2567.1997.d01-2263.x.
The absence of the transcription activator TFE3 impairs activation of B cells in vivo.
Merrell K, Wells S, Henderson A, Gorman J, Alt F, Stall A
Mol Cell Biol. 1997; 17(6):3335-44.
PMID: 9154832
PMC: 232186.
DOI: 10.1128/MCB.17.6.3335.
Effects of inhaled steroid treatment on serum eosinophilic cationic protein (ECP) and low affinity receptor for IgE (Fc epsilon RII/sCD23) in childhood bronchial asthma.
Turktas I, Demirsoy S, Koc E, Gokcora N, Elbeg S
Arch Dis Child. 1996; 75(4):314-8.
PMID: 8984917
PMC: 1511750.
DOI: 10.1136/adc.75.4.314.
Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria.
Perlmann P, Perlmann H, Flyg B, Hagstedt M, ElGhazali G, Worku S
Infect Immun. 1997; 65(1):116-21.
PMID: 8975900
PMC: 174564.
DOI: 10.1128/iai.65.1.116-121.1997.
Elevated soluble CD23 levels in the sera from patients with localized scleroderma.
Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K
Arch Dermatol Res. 1996; 288(2):74-8.
PMID: 8932584
DOI: 10.1007/BF02505047.
Role of IgE immune complexes in the regulation of HIV-1 replication and increased cell death of infected U1 monocytes: involvement of CD23/Fc epsilon RII-mediated nitric oxide and cyclic AMP pathways.
Ouaaz F, Ruscetti F, Dugas B, Mikovits J, Agut H, Debre P
Mol Med. 1996; 2(1):38-49.
PMID: 8900533
PMC: 2230037.
Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.
Matsubara T, Furukawa S, Motohashi T, Okumura K, YABUTA K
Eur J Pediatr. 1995; 154(10):826-9.
PMID: 8529682
DOI: 10.1007/BF01959791.
Tumour necrosis factor-alpha augments the expression of Fc IgE receptor (Fc epsilon RII/CD23) on human monocytic cell lines and down-regulates interleukin-4-driven Fc epsilon RII expression on monocytes.
Gessl A, Willheim M, Agis H, Spittler A, Schedle A, Krugluger W
Immunology. 1993; 78(3):476-81.
PMID: 8478029
PMC: 1421844.
